Magnesia
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
133 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Insulin resistance | D007333 | EFO_0002614 | E88.819 | — | 8 | 2 | 1 | 5 | 15 |
| Syndrome | D013577 | — | — | — | 8 | 3 | 1 | 3 | 14 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | 1 | 4 | 1 | 4 | 10 |
| Hypersensitivity | D006967 | EFO_0003785 | T78.40 | — | 7 | 2 | 1 | 1 | 10 |
| Healthy volunteers/patients | — | — | — | 2 | 1 | — | 1 | 2 | 6 |
| Constipation | D003248 | — | K59.0 | — | — | — | 2 | 3 | 5 |
| Colonoscopy | D003113 | — | — | — | — | — | 4 | — | 4 |
| Colonic diseases | D003108 | — | — | — | — | — | 2 | — | 2 |
| Acute pain | D059787 | — | R52 | — | — | — | 1 | 1 | 2 |
| Rectal diseases | D012002 | — | — | — | — | — | 1 | — | 1 |
Show 21 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 6 | 5 | — | 4 | 13 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | 5 | 4 | — | 5 | 13 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | 8 | 3 | — | 2 | 12 |
| Glucose intolerance | D018149 | HP_0000833 | R73.03 | — | 4 | 1 | — | 2 | 7 |
| Prediabetic state | D011236 | EFO_1001121 | R73.03 | — | 2 | 1 | — | 1 | 4 |
| Magnesium deficiency | D008275 | EFO_1001029 | E61.2 | — | — | 1 | — | 2 | 3 |
| Pre-eclampsia | D011225 | EFO_0000668 | O14 | — | 1 | 1 | — | — | 2 |
| Dyslipidemias | D050171 | — | — | — | 1 | 1 | — | 1 | 2 |
| Inflammatory bowel diseases | D015212 | EFO_0003767 | — | — | — | 1 | — | 1 | 2 |
| Retinal diseases | D012164 | — | H35.9 | — | 1 | 1 | — | — | 2 |
Show 20 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Oxidative stress | D018384 | EFO_1001905 | — | — | 3 | — | — | — | 3 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | — | 1 | — | — | 1 | 2 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 2 | — | — | — | 2 |
| Neoplasms | D009369 | — | C80 | — | 2 | — | — | — | 2 |
| Hot flashes | D019584 | — | — | — | 2 | — | — | — | 2 |
| High-risk pregnancy | D018566 | — | — | — | 1 | — | — | — | 1 |
| Hyperglycemia | D006943 | — | R73.9 | — | 1 | — | — | — | 1 |
| Multiple myeloma | D009101 | — | C90.0 | — | 1 | — | — | — | 1 |
| Plasma cell neoplasms | D054219 | — | — | — | 1 | — | — | — | 1 |
| Diabetic neuropathies | D003929 | EFO_1000783 | — | — | 1 | — | — | — | 1 |
Show 9 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Traumatic brain injuries | D000070642 | — | S06 | 1 | — | — | — | — | 1 |
| Brain injuries | D001930 | — | S06.9 | 1 | — | — | — | — | 1 |
| Post-concussion syndrome | D038223 | EFO_1001827 | F07.81 | 1 | — | — | — | — | 1 |
| Ileus | D045823 | — | K56.7 | 1 | — | — | — | — | 1 |
| Infections | D007239 | EFO_0000544 | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Vascular stiffness | D059289 | — | — | — | — | — | — | 3 | 3 |
| Gastrointestinal diseases | D005767 | — | — | — | — | — | — | 2 | 2 |
| Glucose metabolism disorders | D044882 | — | — | — | — | — | — | 2 | 2 |
| Peripheral arterial disease | D058729 | EFO_0004265 | — | — | — | — | — | 1 | 1 |
| Arterial occlusive diseases | D001157 | EFO_0009085 | — | — | — | — | — | 1 | 1 |
| Peripheral vascular diseases | D016491 | EFO_0003875 | I73.9 | — | — | — | — | 1 | 1 |
| Impulsive behavior | D007175 | — | — | — | — | — | — | 1 | 1 |
| Dyspepsia | D004415 | EFO_0008533 | K30 | — | — | — | — | 1 | 1 |
| Digestive system diseases | D004066 | EFO_0000405 | K92.9 | — | — | — | — | 1 | 1 |
| Diabetic nephropathies | D003928 | EFO_0000401 | — | — | — | — | — | 1 | 1 |
Show 19 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1,128 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use